The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.
 
Kristine Peregrino Lacuna
No Relationships to Disclose
 
Shing M Lee
Consulting or Advisory Role - PTC Therapeutics
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)
 
Liner Ge
No Relationships to Disclose
 
Mihaela Druta
Consulting or Advisory Role - AADi; Adaptimmune; Decipher Biosciences
Speakers' Bureau - AADi; Deciphera
Travel, Accommodations, Expenses - AADi
 
Anthony Paul Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
Mary Louise Keohan
No Relationships to Disclose
 
Mark Agulnik
Consulting or Advisory Role - AADi; Coherus Biosciences; Regeneron
Speakers' Bureau - Bayer; Deciphera
Research Funding - Exelixis (Inst)
 
Melissa Amber Burgess
Consulting or Advisory Role - Rain Therapeutics; SpringWorks Therapeutics
Research Funding - Merck
 
Anna Weinberg Chalmers
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo/Lilly; DePuy Companies (I); ExacTech (I)
Research Funding - BioAtla; Blueprint Medicines; Boehringer Ingelheim; GlaxoSmithKline; TRACON Pharma
Patents, Royalties, Other Intellectual Property - patent pending for hormone supplementation of tendon and ligament repair (I)
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Benjamin Powers
No Relationships to Disclose
 
Mahesh Seetharam
Stock and Other Ownership Interests - BioNTech; crispr therapeutics; Moderna Therapeutics
Honoraria - AADi; Daiichi Sankyo; Deciphera; Horizon CME
 
Brittany L Siontis
No Relationships to Disclose
 
Mia C. Weiss
No Relationships to Disclose
 
Sminu (Sam) Bose
No Relationships to Disclose
 
Tahir Sheikh
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Gary K. Schwartz
Stock and Other Ownership Interests - Bionaut Labs; GenCirq; January Therapeutics
Consulting or Advisory Role - AADi; Agenus; Apexigen; Array BioPharma; Astex Pharmaceuticals; Bionaut Labs; Boehringer Ingelheim; Concarlo; Ellipses Pharma; Epizyme; Gencirq; Ipsen; January Therapeutics; Kirilys Therapeutics; Oncogenuity; OnCusp Therapeutics; PureTech; Sellas Life Sciences; Shanghai Pharma
Research Funding - Adaptimmune (Inst); Astex Pharmaceuticals; Astex Pharmaceuticals (Inst); Calithera Biosciences (Inst); Daiichi Sankyo (Inst); Fortress Biotech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Oxford BioTherapeutics (Inst); SpringWorks Therapeutics (Inst); TopAlliance BioSciences Inc (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
Travel, Accommodations, Expenses - Array BioPharma; Boehringer Ingelheim; Epizyme; Epizyme; Epizyme
 
Matthew Ingham
Consulting or Advisory Role - Apexigen; Caris Life Sciences; Daiichi Sankyo; Epizyme; Xencor
Research Funding - Apexigen (Inst); APICES; Mirati Therapeutics (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech